Collegium Pharma Balance Sheet - Annual (NASDAQ:COLL)

Add to My Stocks
$14.16 $1.16 (7.57%) COLL stock closing price Sep 17, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Collegium Pharma, and helps in stock analysis. Financial strength can be guaged by performing Collegium Pharma stock analysis and by analyzing the balance sheet. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Collegium Pharma had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Collegium Pharma operating cash flow and Collegium Pharma revenue also. Collegium Pharma debt to equity ratio is 5.33.

View latest 10 year balance sheet data to check Collegium Pharma financial performance.
show more
Fiscal year is Jan - Dec20172016201520142013
Marketable Securities-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets3M1.9M1.18M2.86M-
Total Current Assets
Property Plant & Equipment3.49M2.37M1.81M1.41M1.4M
Accumulated Depreciation1.66M1.33M1.07M--
Net Property Plant & Equipment
Investment & Advances-----
Other Non-Current Assets-----
Deferred Charges-----
Deposits & Other Assets-----
Total Assets
Notes Payable---5M-
Accounts Payable5.68M9.1M3.53M2.2M1.21M
Current Portion Long-Term Debt1.47M2.66M2.66M1.19M-
Current Portion Capital Leases-----
Accrued Expenses24.32M8.87M2.22M1.95M1.01M
Income Taxes Payable-----
Other Current Liabilities-4.94M---
Total Current Liabilities
Deferred Taxes/Income-----
Convertible Debt-----
Long-Term Debt-1.47M4.14M6.81M-
Non-Current Capital Leases-----
Other Long-Term Liabilities-----
Total Liabilities
Minority Interest-----
Preferred Stock---77.1M73.8M
Common Stock Net-----
Capital Surplus402.09M358.06M214.06M12.4M12.31M
Retained Earnings-298.04M-223.18M-129M-101.75M-80.53M
Treasury Stock-----
Other Liabilities-----
Shareholders Equity104.08M134.9M85.07M-12.24M5.58M
Total Liabilities & Shareholders Equity135.56M162.01M97.71M5.09M9.03M
All figures in USD. M: Millions of USD, B: Billions of USD.

Looking at Collegium Pharma historical stock prices and the current Collegium Pharma stock price can tell you how the stock price has moved, whereas the Collegium Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: COLL total assets, which was at $135.56M for 2017 is a balance sheet item representing value of what Collegium Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Collegium Pharma for the year 2017 total to $31.48M. Liabilities for a company like Collegium Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Collegium Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio